The Glaucoma and Retinopathy Screening Study
The Glaucoma and Retinopathy Screening Study (GRaSS)
Massachusetts Eye and Ear Infirmary
2,000 participants
Jul 16, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to learn if a new screening approach including an artificial intelligence algorithm that analyzes fundus photographs, measurement of eye pressure and visual field testing works to screen for glaucoma. Participants will: Have an image of their fundus (back of the eye) taken as part of their diabetic eye screening Have a measurement of their eye pressure If needed, have a test of their side vision using a headset
Eligibility
Inclusion Criteria2
- Individuals with diabetes undergoing AI-based screening for diabetic retinopathy using the LumineticsCore (Digital Diagnostics) system for clinical care at primary care centers.
- Individuals who are able and willing to provide informed consent for participation in the study.
Interventions
AI analysis of fundus photographs to detect signs of glaucoma, added to AI-based diabetic eye disease screening performed for routine clinical care
Intraocular pressure measurement by Icare tonometer
Virtual Reality Visual Field Testing by the Olleyes device for participants suspected of having glaucoma
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06882356